Bausch Health Companies Inc Share Price Toronto S.E.
Equities
CA91911K1021
Pharmaceuticals
Sales 2024 * | 9.4B 12.85B 748B | Sales 2025 * | 9.67B 13.22B 770B | Capitalization | 2.52B 3.45B 201B |
---|---|---|---|---|---|
Net income 2024 * | 148M 202M 11.79B | Net income 2025 * | 389M 532M 30.98B | EV / Sales 2024 * | 2.44 x |
Net Debt 2024 * | 20.44B 27.95B 1,627B | Net Debt 2025 * | 19.09B 26.1B 1,520B | EV / Sales 2025 * | 2.24 x |
P/E ratio 2024 * |
20.4
x | P/E ratio 2025 * |
6.53
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.62% |
Latest transcript on Bausch Health Companies Inc
Managers | Title | Age | Since |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 23/05/22 |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 31/07/08 |
John Paulson
CHM | Chairman | 68 | 31/05/17 |
Steven Miller
BRD | Director/Board Member | 35 | 16/03/21 |
1st Jan change | Capi. | |
---|---|---|
+29.38% | 684B | |
+30.34% | 568B | |
-4.02% | 361B | |
+17.60% | 329B | |
+3.94% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+6.73% | 166B |